J&J says its lung cancer drug combination keeps people alive longer
- Posted on January 7, 2025
- By CNBC
- 4 Views
J&J says its lung cancer drug combination keeps people alive longer
Johnson & Johnson said its lung cancer regimen – Rybrevant plus Lazcluze – keeps people alive for at least a year longer than AstraZeneca's Tagrisso.
